![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Mitosol (Mitomycin-C) is an antibiotic, isolated from the broth of Streptomyces verticillus Yingtanensis, intended for topical application to the surgical site of glaucoma filtration surgery.
Lead Product(s): Mitomycin
Therapeutic Area: Ophthalmology Product Name: Mitosol
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable January 03, 2023